Not Yet Recruiting
Phase 2 Study of Pembrolizumab and Lenvatinib in Anal Squamous Cell Cancer
NCT07680088
- Conditions
- Anal Squamous Cell Carcinoma, Anus Diseases, Anus Neoplasms, +11 more
- Locations
-
Not specified